Senate Passes $2 Trillion Coronavirus Relief Package
The Senate has passed a $2 trillion coronavirus relief package that includes cash to Americans and help for small businesses.
Health & Safety
Defense Secretary Esper Says Military Has 'Limited Capacity' To Provide Hospital Beds
New York alone could need nearly 90,000 more beds to deal with coronavirus patients, but in an interview with NPR, Mark Esper cautioned the Pentagon can only offer "a few thousand beds ... at most."
Infectious Disease Specialist Answers Listener Questions About The Coronavirus
NPR's Michel Martin speaks with infectious disease specialist Dr. Amesh Adalja of the Johns Hopkins Bloomberg School of Public Health to answer listener questions about the coronavirus.
Why The Coronavirus Outbreak Has Hit New York City Especially Hard
NPR national and science correspondents answer listener questions about why the coronavirus outbreak has been especially bad in New York City and the surrounding region.
Views From A New York City Midwife During The Epidemic
NPR's Michel Martin, Hansi Lo Wang and Rebecca Hersher speak with New York City midwife Eugenia Montesinos about the effect the coronavirus is having on her work.
What Happened Today: Listener Questions About The Economic Relief Bill, More
NPR economics and science correspondents answer listener questions about what the federal government is doing. Are the latest measures working? What is happening with the economic relief bill?
50,000 Americans Stranded Abroad By Coronavirus Events, State Department Says
They're seeking help as countries close borders and flights are canceled to try to control the spread of the virus.
FACT CHECK: Testing Should Take Place Wherever There Are Cases Despite Trump's View
Trump said he doesn't think testing needs to happen in entire states in the Midwest. But there are cases in all 50 states, and to stop the spread, testing needs to take place.
ICU Bed Capacity Varies Widely Nationwide. See How Your Area Stacks Up
An NPR analysis of the nation's 100,000 ICU beds finds some communities can accommodate far more critically ill patients than others, signaling potential disparities in care in the COVID-19 pandemic.
Gilead Declines 'Rare Disease' Status For Experimental Coronavirus Drug
By renouncing the special status, Gilead Sciences lets go of tax breaks, fee waivers and seven years without generic competition for remdesivir, its experimental COVID-19 treatment.